Guidelines for pre-clinical animal and cellular models of MuSK-myasthenia gravis.
Muscle-specific tyrosine kinase (MuSK) autoantibodies are the hallmark of a form of myasthenia gravis (MG) that can challenge the neurologist and the experimentalist. The clinical disease can be difficult to treat effectively. MuSK autoantibodies affect the neuromuscular junction in several ways. Wh...
Main Authors: | Phillips, W, Christadoss, P, Losen, M, Punga, A, Shigemoto, K, Verschuuren, J, Vincent, A |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado: |
Academic Press Inc.
2015
|
Títulos similares
-
Myasthenia gravis with MuSK antibodies
por: Farrugia, M, et al.
Publicado: (2005) -
The role of muscle-specific tyrosine kinase (MuSK) and mystery of MuSK myasthenia gravis.
por: Koneczny, I, et al.
Publicado: (2014) -
The role of muscle-specific tyrosine kinase (MuSK) and mystery of MuSK myasthenia gravis
por: Koneczny, I, et al.
Publicado: (2014) -
Potential mechanisms in MuSK-myasthenia gravis
por: Koneczny, I
Publicado: (2014) -
MuSK-Myasthenia Gravis Unmasked by Hydroxychloroquine
por: Shalini Bhaskar, et al.
Publicado: (2022-01-01)